Financials
- Market Capitalization 11.71 B
- Employee 711
- Founded 2004
- CEO Christopher Richard Anzalone
- Website www.arrowheadpharma.com
- Headquarter Delaware, United States
- FIGI BBG000BRVKH0
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-37.39
ratio cours/chiffre d'affaires
16.85
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 806 | CORT Corcept Therapeutics Incorporated - Common Stock | 114.58 USD | +1.09% | -6.19% | +0.37% | +56.17% | 12.39 B USD | ||
| 814 | HALO Halozyme Therapeutics, Inc. - Common Stock | 107.34 USD | +0.80% | -1.47% | +29.95% | +60.69% | 12.18 B USD | ||
| 847 | TECH Bio-Techne Corp - Common Stock | 72.26 USD | -0.07% | -0.11% | +0.17% | +33.39% | 11.33 B USD | ||
| 866 | SMMT Summit Therapeutics Inc. - Common Stock | 14.19 USD | +4.19% | +7.26% | +9.58% | -28.55% | 11.32 B USD |